GEISINGER STLUKES — History
CCN 390332 | 3-year financial timeline | COVID resilience: 100/100
🛡️ Public data only — no PHI permitted on this instance.
$74M
Latest Revenue (FY2022)
+119.0%
Revenue CAGR (3yr)
8.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | $69M | $74M | +6.6% | +119.0% |
| Operating Expenses | $30M | $61M | $68M | +10.3% | +50.3% |
| Operating Margin | -94.6% | 11.5% | 8.4% | -27.1% | +0.0% |
| Net Income | $-15M | $8M | $6M | -22.3% | +0.0% |
| Licensed Beds | 32 | 40 | 60 | +50.0% | +36.9% |
| Total Patient Days | 4,715 | 14,567 | 14,173 | -2.7% | +73.4% |
| Medicare Day % | 43% | 40% | 40% | -1.2% | -4.5% |
| Medicaid Day % | 2% | 2% | 6% | +239.0% | +72.0% |
COVID Impact & Recovery
Resilience Score: 100/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +379.8% ($15M → $74M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+119.0%
This Hospital
+7.6%
State Avg
Latest Margin
8.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $103M | 59.8% |
| FY2024 (proj) | $133M | 111.3% |
| FY2025 (proj) | $162M | 162.8% |